NCT01524276

Product Surveillance Registry

Medtronic Product Surveillance Registry

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100,000 (estimated)
• Sponsor: Medtronic · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Conditions

• Cardiac Rhythm Disorders
• Urological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Digestive Disorders
• Intracranial Aneurysm
• Mechanical Circulatory Support
• Respiratory Therapy
• Aortic, Peripheral Vascular and Venous Disorders
• Minimally Invasive Surgical Procedures
• Diagnostic Techniques and Procedures
• Surgical Procedures, Operative
• Renal Insufficiency
• Neurovascular
• Coronary Artery Disease
• Ear, Nose and Throat Disorder

Timeline

• Start date: 2012-01-01
• Primary completion: 2040-01-01
• Completion: 2040-01-01
• First posted: 2012-02-01
• Last updated: 2026-03-27

Locations

389 sites across 41 countries: United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Kuwait, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Poland, Portugal, Puerto Rico, Saudi Arabia, Serbia, Slovakia, South Korea, Spain, Sweden, Switzerland, Taiwan, United Kingdom